Abstract
Fluoroquinolones have been studied extensively as prophylaxis in neutropenic cancer patients. There is a large body of evidence suggesting that fluoroquinolones are a valuable choice for preventing bacterial infections in neutropenic cancer patient. As yet, there is no question that prophylaxis with fluoroquinolones has led to a decrease in the occurrence of gram-negative infections in neutropenic patients. By contrast, the benefits of fluoroquinolone prophylaxis on other parameters of infection-related morbidity and on the occurrence of infection-related mortality are not clear. Moreover, the use of fluoroquinolones is not without risk. Reports of fluoroquinolone-resistant Escherichia coli causing bacteremia among cancer patients are matter of concern. Recent well conducted, large clinical trials confirm the long lasting interest in the use of fluoroquinolones prophylaxis. Moreover, a reduction in mortality has been demonstrated in recent metaanalyses, though the generalizability of this finding is uncertain. Reports from cancer centers in Europe have shown a rebound of gram-negative bacteremias after discontinuation in the use of prophylaxis with fluoroquinolones. In light of the these findings, prophylaxis with a quinolone during granulocytopenia, where resistance permits, is still appropriate.
Keywords: Granulocytopenia, antibiotic prophylaxis, quinolones, cancer
Current Cancer Therapy Reviews
Title: Fluoroquinolones Prophylaxis of Bacterial Infections in Neutropenic Patients: Time to Re-Evaluate
Volume: 3 Issue: 3
Author(s): Mario Cruciani
Affiliation:
Keywords: Granulocytopenia, antibiotic prophylaxis, quinolones, cancer
Abstract: Fluoroquinolones have been studied extensively as prophylaxis in neutropenic cancer patients. There is a large body of evidence suggesting that fluoroquinolones are a valuable choice for preventing bacterial infections in neutropenic cancer patient. As yet, there is no question that prophylaxis with fluoroquinolones has led to a decrease in the occurrence of gram-negative infections in neutropenic patients. By contrast, the benefits of fluoroquinolone prophylaxis on other parameters of infection-related morbidity and on the occurrence of infection-related mortality are not clear. Moreover, the use of fluoroquinolones is not without risk. Reports of fluoroquinolone-resistant Escherichia coli causing bacteremia among cancer patients are matter of concern. Recent well conducted, large clinical trials confirm the long lasting interest in the use of fluoroquinolones prophylaxis. Moreover, a reduction in mortality has been demonstrated in recent metaanalyses, though the generalizability of this finding is uncertain. Reports from cancer centers in Europe have shown a rebound of gram-negative bacteremias after discontinuation in the use of prophylaxis with fluoroquinolones. In light of the these findings, prophylaxis with a quinolone during granulocytopenia, where resistance permits, is still appropriate.
Export Options
About this article
Cite this article as:
Mario Cruciani , Fluoroquinolones Prophylaxis of Bacterial Infections in Neutropenic Patients: Time to Re-Evaluate, Current Cancer Therapy Reviews 2007; 3 (3) . https://dx.doi.org/10.2174/157339407781368314
DOI https://dx.doi.org/10.2174/157339407781368314 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Role of Infrared Spectroscopy and Imaging in Cancer Diagnosis
Current Medicinal Chemistry Pharmacological Applications of Lignins and Lignins Related Compounds: An Overview
Current Organic Chemistry Tribulus arabicus and Tribulus macropterus are Comparable to Tribulus terrestris: An Antioxidant Assessment
Current Bioactive Compounds Next-Generation Anticancer Metallodrugs
Current Topics in Medicinal Chemistry Hormones and their Receptors Bridge Fat and Bone Metabolisms
Current Signal Transduction Therapy Vascular Calcification Revisited: A New Perspective for Phosphate Transport
Current Cardiology Reviews Retrotransposon-Adenovirus Hybrid Vectors: Efficient Delivery and Stable Integration of Transgenes via a Two-Stage Mechanism
Current Gene Therapy Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Manganese Superoxide Dismutase (Sod2) and Redox-Control of Signaling Events That Drive Metastasis
Anti-Cancer Agents in Medicinal Chemistry Biological Basis of Novel Therapies for Myelodysplastic Syndrome
Current Cancer Therapy Reviews Intrinsic Disorder in Male Sex Determination: Disorderedness of Proteins from the Sry Transcriptional Network
Current Protein & Peptide Science Novel Vitreous Modulators for Pharmacologic Vitreolysis in the Treatment of Diabetic Retinopathy
Current Pharmaceutical Biotechnology Anti-Cancer Compounds from Terrestrial and Marine Resources -In silico and Experimental Studies
Current Computer-Aided Drug Design Effectiveness of Two Novel Anionic and Cationic Platinum Complexes in the Treatment of Osteosarcoma
Anti-Cancer Agents in Medicinal Chemistry Effect of Environmental Contaminants on Mammalian Testis
Current Molecular Pharmacology An Update on Drug Interactions with the Herbal Medicine Ginkgo biloba
Current Drug Metabolism Gene Electrotransfer: A Mechanistic Perspective
Current Gene Therapy Signal Transduction Inhibitors in the Treatment of Breast Cancer
Current Medicinal Chemistry - Anti-Cancer Agents Molecular Symmetry: A Structural Property Frequently Present in New Cytotoxic and Proapoptotic Drugs
Mini-Reviews in Medicinal Chemistry Lipases in Medicine: An Overview
Mini-Reviews in Medicinal Chemistry